Apama Medical, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Apama Medical, Inc. - overview
Established
2009
Location
Campbell, CA-California, US
Primary Industry
Medical Devices & Equipment
About
Apama Medical, Inc. specializes in developing innovative cardiac devices to enhance minimally invasive electrophysiology procedures, focusing on improving patient outcomes and treatment effectiveness. Founded in 2009 and headquartered in Campbell, US, Apama Medical, Inc. designs cardiac devices for electrophysiology.
The company was acquired by Boston Scientific Corporation on October 2, 2017, for approximately USD 300 mn, which included USD 175 mn upfront and contingent payments based on regulatory milestones. The acquisition marked a strategic pivot in Boston Scientific's portfolio, enhancing their offerings in electrophysiology. Apama Medical, Inc. develops advanced medical devices tailored for cardiac care, specifically targeting electrophysiology.
Their product line is focused on enabling minimally invasive procedures that aim to treat various cardiac conditions, thus improving patient management and outcomes. The company’s technology is designed to assist healthcare providers in performing efficient procedures, ultimately enhancing patient care. Apama Medical, Inc. generates revenue through the sale of its specialized cardiac devices to healthcare institutions, primarily hospitals and surgical centers.
The revenue model includes direct sales and partnerships with distributors, ensuring that their innovative products reach a wide array of healthcare providers. This structured approach facilitates predictable revenue streams as they cater to specific needs within the healthcare sector. With the acquisition by Boston Scientific, Apama Medical, Inc. plans to leverage its resources to develop and launch new cardiac devices aimed at enhancing electrophysiological treatments.
The company is anticipated to focus on expanding its presence in North America and Europe by 2025, utilizing the recent funding from the acquisition to support product development and market penetration initiatives. The strategic investment will also enable the company to explore additional market opportunities in Asia-Pacific, aligning with the healthcare industry's growing demand for innovative cardiac solutions.
Current Investors
Silicon Valley Bank, Broadview Ventures, ONSET Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment
Website
www.apamamedical.com
Total Amount Raised
Subscriber access only
Apama Medical, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Completed | Apama Medical, Inc. | - | ||||||||
| Series C | Completed | Apama Medical, Inc. | - | ||||||||
| Venture Debt | Completed | Apama Medical, Inc. | - | ||||||||
| Series B | Completed | Apama Medical, Inc. | - | ||||||||
| Series A | Completed | Apama Medical, Inc. | - |
Displaying 1 - 5 of 6
Apama Medical, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.